Sriram Vaidyanathan

Dr. Sriram Vaidyanathan

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2016 in Accounts of Chemical Research
Verified
Journal Article
Closed access
SVSriram Vaidyanathan
Sriram Vaidyanathan
BOBradford G. Orr
Bradford G. Orr
MHMark M. Banaszak Holl
Mark M. Banaszak Holl

1 January 2022 in Molecular Therapy
Verified
Journal Article
Open access
SVSriram Vaidyanathan
Sriram Vaidyanathan
RBRon Baik
Ron Baik
LCLu Chen
Lu Chen
DBDawn T. Bravo
Dawn T. Bravo
CSCarlos J. Suarez
Carlos J. Suarez
MPMatthew H. Porteus
Matthew H. Porteus
Cystic fibrosis (CF) is a monogenic disease caused by impaired production and/or function of the CF transmembrane conductance regulator (CFTR) protein. Although we have previously shown correction of the most common pathogenic mutation, there are many other pathogenic mutations throughout the CF gene. An autologous airway stem cell therapy in which the CFTR cDNA is precisely inserted into the CFTR locus may enable the development of a durable cure for almost all CF patients, irrespective of the causal mutation. Here, we use CRISPR-Cas9 and two adeno-associated viruses (AAVs) carrying the two halves of the CFTR cDNA to sequentially insert the full CFTR cDNA along with a truncated CD19 (tCD19) enrichment tag in upper airway basal stem cells (UABCs) and human bronchial epithelial cells (HBECs). The modified cells were enriched to obtain 60%-80% tCD19+ UABCs and HBECs from 11 different CF donors with a variety of mutations. Differentiated epithelial monolayers cultured at air-liquid interface showed restored CFTR function that was >70% of the CFTR function in non-CF controls. Thus, our study enables the development of a therapy for almost all CF patients, including patients who cannot be treated using recently approved modulator therapies.

3 May 2016 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SVSriram Vaidyanathan
Sriram Vaidyanathan
JCJunjie Chen
Junjie Chen
BOBradford G. Orr
Bradford G. Orr
MHMark M. Banaszak Holl
Mark M. Banaszak Holl

7 May 2015 in ACS Nano
Verified
Journal Article
Closed access
SVSriram Vaidyanathan
Sriram Vaidyanathan
KAKevin B. Anderson
Kevin B. Anderson
RMRachel L. Merzel
Rachel L. Merzel
BJBinyamin Jacobovitz
Binyamin Jacobovitz
MKMilan P. Kaushik
Milan P. Kaushik
MHMark M. Banaszak Holl
Mark M. Banaszak Holl

9 October 2013 in Soft Matter
Verified
Journal Article
Closed access
PDF file
MDMallory A. van Dongen
Mallory A. van Dongen
SVSriram Vaidyanathan
Sriram Vaidyanathan
MHMark M. Banaszak Holl
Mark M. Banaszak Holl
The desire to synthesize soft supramolecular structures with size scales similar to biological systems has led to work in assembly of polymeric nanomaterials. Recent advances in the isolation of generationally homogenous poly(amidoamine) (PAMAM) dendrimer enables their use as quantized building blocks. Here, we report their assembly into precise nanoclusters. In this work, click-functional ligands are stochastically conjugated to monomeric generation 5 PAMAM dendrimer and separated via reverse-phase HPLC to isolate dendrimers with precise numbers of click ligands per dendrimer particle. The click-ligand/dendrimer conjugates are then employed as modular building blocks for the synthesis of defined nanostructures. Complimentary click chemistry employing dendrimers with 1, 2, 3, or 4 ring-strained cyclooctyne ligands and dendrimers with 1 azide ligand were utilized to prepare megamer structures containing two to five 30 000 kDa monomer units as characterized by mass spectrometry, size exclusion chromatography, and reverse-phase liquid chromatography. The resulting structures are flexible with masses ranging from 60 000 to 150 000 kDa, and are soluble in water, methanol, and dimethylsulfoxide.

5 February 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
CDCasey A. Dougherty
Casey A. Dougherty
SVSriram Vaidyanathan
Sriram Vaidyanathan
BOBradford G. Orr
Bradford G. Orr
MHMark M. Banaszak Holl
Mark M. Banaszak Holl